Table 4.

End of follow up HIV treatment outcomes and last known viral load, participants stratified by sex and enrolment pre-EAT or concurrently with EAT

	SCI living with HIV	Enrolled in HIV Care Pre-EAT			Enrolled in HIV Care Concurrently with Enrolment in EAT			P-value
	Totala N = 75	Malesa N = 21	Femalesa N = 39	Totala N = 60	Malesa N = 8	Femalesa N = 7	Totala N = 15
ART Regimen
First line	66	17	34	51	8	7	15
Second line	9	4	5	9	0	0	0
Viral load measure ever?
Yes	64	19	37	56	4	4	8
No	11	2	2	4	4	3	7
Viral load measure during EAT?
Yes	58	16	34	50	4	4	8
No	17	5	5	10	4	3	7
Viral load at final measure during the study perioda	n = 58	n = 16	n = 34	n = 50	n = 4	n = 4	n = 8
< 200 copies / ml	40	10	24	34	4	2	6
< 1000 copies / ml	4	1	3	4	0	0	0
> 1000 copies / ml	14	5	7	12	0	2	2
Median time (months) to ART initiation from enrolment in care (IQR)	3 (0–34)	6(0–39)	6(0–35)	6(0–38)	0	0	0	< 0.001
Median time (months) to first episode of viral suppression from ART initiation (IQR)b	9(6–25)	7(4–54)	11(8–30)	11(7–38)	6(6–6)	5(5–6)	6(5–6)	0.003

^aNumbers in the three rows below total to the value denoted by “n”, the number of participants who had a viral load measure during the study period

^bComparison of median time using the Wilcoxon rank sum test

Bold values indicate statistical significance